The Agilent Technologies-backed tissue analysis device maker has selected the Nasdaq Global Select Market for its initial public offering.
Month: March 2021
Eli Lilly leads ImmuneOnco to $89m series C
Lilly Asia Ventures has returned to co-lead the cancer immunotherapy developer’s series C round with Greater Bay Area Homeland Investments.
Lava breaks through to public markets
Novo, Sanofi and Merck & Co all scored exits as the cancer drug developer, which had been spun off by Biox Biosciences, floated in a $101m offering.
Eliem emerges with $80m
Access Biotechnology is among the initial investors disclosed by Eliem Therapeutics, which is targeting neuronal excitability disorders.
Ajaib adjusts series A round to $90m
SoftBank Ventures Asia and Bangkok Bank were among the investors that added $65m to the online share trading platform’s series A round.
Pilot upgrades series C round to $100m
The business service provider has added $40m to the round’s Stripe-backed first close, doubling its valuation to $1.2bn in the process.
First quarter sees 15 deals worth at least $500m
Back in 2013-2014 it was possible to almost see in real time the jump in professionalism and ambition of investors backing entrepreneurs through tracking the number of large rounds of at least $100m being done and hence the valuation increases of the overall businesses.
Idelic trucks in $20m
The truck management platform developer increased its overall funding to $31m in a series B round featuring Axa Venture Partners.
DotPe tots up series A funding
The $27.5m round was led by PayU and included another of the e-commerce platform’s existing investors, Info Edge Ventures, as well as Google.
WeWork makes space for reverse merger
SoftBank-backed co-working space provider WeWork will finally get a public listing, at a $9bn initial enterprise value.
UiPath officially gets on the IPO road
The Alphabet and Tencent-backed automation software producer, valued at $35bn as of last month, has filed for a $1bn offering.
ABL Space Systems ascends to $170m series B
The Lockheed Martin-backed satellite launch system developer has now raised at least $219m of funding ahead of its first official launch.
Yunxuetang floats to $190m series E close
The SIG and Tencent-backed corporate training provider has completed its latest round at a $1bn valuation, two months after securing the $100m first tranche.
Edgewise executes $176m initial public offering
The Novo-backed musculoskeletal disease therapy developer floated in an upsized IPO before its share price almost doubled on its first day of trading.